Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
References
1. Hebb, J.P.O. et al. (2018) Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression. Cancer Immunol Immunother. 67 (1): 47-60. 2. Sandin, L.C. et al. (2014) Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer. Cancer Immunol Res. 2(1): 80-90.USBio References
No references available